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Abstract 13 
Objectives. We have recently shown that inactivation of any of the multidrug efflux 14 
systems of Salmonella results in loss of ability to form a competent biofilm, the aim of 15 
this study was to determine the mechanism linking multidrug efflux and biofilm 16 
formation.  17 
Methods. Mutants lacking components of the major AcrAB-TolC system were 18 
investigated for their ability to form a biofilm, aggregate and produce biofilm matrix 19 
components. The potential for export of a biofilm relevant substrate via efflux pumps 20 
was investigated as well as expression of genes that regulate multidrug efflux and 21 
production of biofilm matrix components.  22 
Results. Mutants of Salmonella enterica serovar Typhimurium which lack TolC or 23 
AcrB but surprisingly not AcrA were compromised in their ability to form biofilms. 24 
This defect was not related to changes in cellular hydrophobicity, aggregative ability 25 
or export of any biofilm specific factor. The biofilm defect associated with inactivation 26 
of acrB or tolC resulted from transcriptional repression of curli biosynthesis genes 27 
and consequent inhibition of the production of curli by mutants lacking AcrB or TolC. 28 
This repression was associated with up-regulation of the global regulator, ramA and 29 
artificial over-expression of ramA, marA and soxS each decreased biosynthesis of 30 
curli, and inhibited biofilm formation. However, inactivation of these regulators did not 31 
rescue the ability of efflux mutants to form a biofilm. 32 
Conclusions. This work shows biofilm formation and multidrug efflux are co-33 
ordinately regulated, and that transcriptional repression of curli biosynthesis causes 34 
a lack of biofilm formation which occurs in response to lack of efflux activity or as a 35 
result of over-expression of global regulators ramA, marA and soxS. 36 
37 
  
Introduction 38 
Bacterial biofilms are a major clinical and industrial problem and eradication of 39 
biofilms presents a challenge for antimicrobial chemotherapy.1-3 Bacteria within a 40 
biofilm are encased within an extracellular matrix which commonly includes 41 
polysaccharides, proteins and other species specific components.1,4 Multidrug 42 
resistance efflux (MDR) pumps are transporters which can export a wide range of 43 
xenobiotics including antibiotics, dyes, biocides and other toxic molecules preventing 44 
lethal accumulation within the cell.5 The expression of efflux pumps is tightly 45 
regulated and efflux genes are usually subject to control by both local and global 46 
regulators.5 Salmonella enterica serovar Typhimurium (S. Typhimurium hereafter) 47 
has nine MDR systems from four separate protein families; the major system in 48 
Salmonella is the AcrAB-TolC RND system.6 The homologous global transcription 49 
regulators MarA, RamA and SoxS can all increase expression of acrAB in response 50 
to stress.7-8 We have recently described an inability to form a competent biofilm 51 
associated with inactivation of any of the MDR systems of S. Typhimurium including 52 
those which are normally cryptic in standard laboratory conditions.9 We found that 53 
production of curli, a major component of the Salmonella biofilm extracellular matrix 54 
was defective in all these strains, suggesting a common mechanism for the lack of 55 
biofilm formation in all mutants.  56 
Here, using AcrAB-TolC as a paradigm we investigated the mechanism by which 57 
loss of efflux activity results in a lack of curli production. We ruled out export of a 58 
factor crucial for biofilm development via AcrAB-TolC and also showed that 59 
inactivation of components of AcrAB-TolC did not alter cellular hydrophobicity. 60 
However, inactivation of efflux components was found to significantly alter 61 
expression of biofilm related genes. We demonstrate that the biofilm defect of 62 
  
mutants lacking AcrB or TolC is due to transcriptional repression of curli biosynthesis 63 
in the efflux mutants. Additionally, over-expression of the global regulators ramA, 64 
marA or soxS resulted in repression of curli biosynthesis and loss of biofilm 65 
formation. This work demonstrates a mechanism whereby loss of MDR efflux pumps 66 
impacts production of a biofilm due to co-ordinated regulation of efflux and biofilm 67 
formation.  68 
69 
  
Materials and methods 70 
Strains and growth media 71 
All strains used in this study and their origins are shown in Table 1. S. Typhimurium 72 
ATCC 14028S (L828) was used as a control strain throughout. Isogenic derivatives, 73 
L829 (tolC::cat) and L830 (acrB::aph) have been described previously,6 New 74 
mutants were created by transduction of mutant alleles into L828, and resistance 75 
marker cassettes were removed by plasmid pCP20 as previously described.10 To 76 
select for transductants, 100 µl from each transduction reaction was spread onto LB 77 
plates supplemented with 50 mg/L of kanamycin or 25 mg/L of chloramphenicol and 78 
incubated overnight at 37°C. Transfer of each mutant allele was verified by PCR and 79 
sequencing. Strains were stored at -20°C on Protect™ beads and routinely cultured 80 
on Luria-Bertani agar or broth unless stated otherwise. Over-expression and 81 
complementation plasmids containing marA, soxS or ramA were constructed in 82 
pTRC and pWKS30 as previously described. 7 83 
Biofilm formation assays 84 
Various models were used to analyse biofilm formation in this study.  85 
For crystal violet biofilm assays, overnight cultures of strains were diluted in fresh 86 
Luria-Bertani broth without salt to an optical density of 0.1 at 600 nm. 96 well 87 
polystyrene microtitre trays (Sterilin) were inoculated with 200 µl of this suspension 88 
and incubated at 30°C for 48 hours with gentle agitation. After incubation liquid was 89 
removed from all wells and wells were washed with sterile distilled water to remove 90 
any unbound cells. Biofilms were stained by adding 200 µl of 1% crystal violet to 91 
appropriate wells for 15 minutes. Crystal violet was removed and each well washed 92 
with sterile distilled water to remove unbound dye. The stained biofilm was 93 
solubilised by adding 200 µl of 70% ethanol and optical density measured at 600 nm 94 
  
using a FLUOstar Optima (BMG labtech). All biofilm assays were repeated three 95 
times with two biological and four technical replicates per repeat. 96 
To determine whether biofilm formation in L829 (tolC::cat) and L830 (acrB::aph) 97 
could be rescued by co-incubation with L828 (wild-type), strains were grown 98 
separated by a 0.45 µm membrane and biofilms formed as in the crystal violet assay 99 
but in 500 µl volumes in 24 well transwell plates. Assays were repeated with and 100 
without the presence of L828 (wild-type) in the upper ‘insert’ chamber with liquid 101 
contiguous between the upper and lower chambers. Biofilms were stained with 102 
crystal violet and quantified as above. Assays were repeated with addition of either a 103 
mid-logarithmic or stationary phase culture of L828 (wild-type) to assess whether 104 
growth phase had an impact upon production of any soluble biofilm promoting factor. 105 
Biofilm formation under flow conditions were formed and visualised using a Bioflux 106 
microfluidic system (Fluxion) and phase contrast microscopy. Flow channels were 107 
inoculated with overnight cultures diluted in LB broth without salt to an optical density 108 
of 0.8 at 600 nm, plates were then incubated at 30ºC for three hours to allow the 109 
bacteria to adhere to the flow channels. Fresh LB broth without salt was then applied 110 
to the inlet wells of the plate and pumped through the flow cells at a force of 0.3 111 
dynes at 30ºC for 48 hours. Phase contrast microscopy was used to visualise the 112 
biofilms formed at x10m, x20 and x40 magnification.  113 
Aggregation assays 114 
To examine whether loss of acrB or tolC led to alteration in cellular hydrophobicity or 115 
aggregative ability two different assays were used. 116 
To measure the time taken for strains to settle, strains were incubated overnight in 117 
10 ml LB (without salt) broths with shaking (150 rpm) before being placed statically 118 
on the bench. Samples (100 µl) were taken periodically from immediately below the 119 
  
surface of the liquid and the optical density at 600 nm measured and recorded. 120 
Enteroaggregative E. coli O42 was used as a positive control. 121 
To determine whether there were any intrinsic differences in aggregative ability of 122 
each strain ammonium sulphate was used to induce aggregation of bacterial cells, a 123 
4 M stock of (NH4)2SO4 was made in 1 X PBS and adjusted to a pH 6.8. This stock 124 
was then serially diluted and mixed 1:1 (in 100 µl final volume) with bacterial 125 
suspensions (adjusted from an overnight culture to an OD 570 nm of 0.8) for each 126 
strain. These suspensions were immediately added to a microscope slide and 127 
rocked gently for 30 min before aggregation scored visually under a microscope as 128 
the presence of a precipitate. The lowest concentration of (NH4)2SO4 required to 129 
induce aggregation was recorded for each strain. 130 
Artificial over-expression of ramA, soxS and marA 131 
pTrc-ramA carrying an IPTG inducible ramA was transformed into L828 (wild-type) to 132 
observe the phenotypic effects of over expressing ramA.11 pTrc-soxS and pTrc-marA 133 
were constructed in a similar manner and introduced into L828 (wild-type), L829 134 
(tolC::cat) and L830 (acrB::aph). Plasmid DNA was harvested from 10 ml cultures of 135 
strains containing plasmids after overnight incubation in LB broth at 37°C using the 136 
QIAprep® Spin Cell Mini Kit (QIAGEN, U.K). The resulting plasmid DNA was 137 
analysed by agarose gel electrophoresis and quantified using Gene Tools software 138 
(Syngene, Cambridge, U.K).  Plasmid DNA was transferred into recipient cells by 139 
electroporation. The impact of over-expression of each of the regulators on biofilm 140 
formation was investigated in the crystal violet assay; wells containing plasmids were 141 
supplemented with 100 mg/L of ampicillin and 1 mM IPTG to induce gene 142 
expression.  143 
Determination of gene expression 144 
  
The temporal and spatial expression of ramA, marA and soxS within biofilms was 145 
visualised using promoter-gfp fusion reporter constructs in pMW82.12 Strains 146 
carrying reporter plasmids were grown overnight in LB containing 100 mg/L of 147 
ampicillin then adjusted in PBS to an optical density of 0.1 at 600nm. Spots ( 5 µl) 148 
were inoculated onto LB – NaCl agar plates containing 100 mg/L of ampicillin and 40 149 
mg/L of Congo red and incubated statically at 30 °C. Fluorescence of colonies was 150 
visualised after 24 and 48 h using a Nikon SMZ800 microscope (with Integilight C-151 
HGFI fluorescence module attachment) and representative images captured. The 152 
expression of each regulator gene in response to addition of EIs was also inferred 153 
from measurements of fluorescence (Ex 487, Em 507) using a FLUOstar OPTIMA 154 
(BMG Labtech, U.K). Fluorescence was measured in a wild-type strain every 10 min 155 
over a 5 h period after the addition of a range of concentrations of the three EIs; 156 
PAβN, CCCP and chlorpromazine. Strains were grown in 100 µl of LB broth 157 
(inoculated with ~107 cfu/ml) at 30°C with shaking throughout the experiment. 158 
Induction of expression of each gene was calculated as the ration of average 159 
expression (based on 8 biological replicates) of induced samples compared to un-160 
induced controls. The students ‘t’ test was used to determine significance of 161 
differences in ramA expression.  162 
The expression of marA, ramA, soxS, rob and 16S rRNA were also determined by 163 
reverse-transcriptase PCR as previously described.7 The expression of csgBAC and 164 
csgDEFG were all determined using comparative RT-PCR, again as previously 165 
described.9  All primers used in this study are shown in Table 2. 166 
  
Staining of curli fimbriae 167 
Phenotypic differences in curli production were visualised by growing strains on agar 168 
containing Congo red (40 mg/L, Sigma-Aldrich Ltd., UK) and incubating them for 48h 169 
at 30° C as described previously. 9 170 
171 
  
Results 172 
Mutants lacking a functional acrB or tolC do not form competent biofilms 173 
whereas a mutant lacking acrA is able to biofilm 174 
A high throughput biofilm assay using crystal violet to stain cells adhered to a 96 well 175 
plate showed a significant decrease in the biofilm formation ability of L829 (tolC::cat) 176 
and L830 (acrB::aph) (figure 1). However, genetic inactivation of acrA (L1271 177 
(acrA::aph)), the periplasmic adapter protein, had no negative effect on biofilm 178 
formation. The phase contrast microscopy images from biofilms formed in a flow cell 179 
under shear stress showed a similar pattern as the crystal violet assay with L828 180 
(wild-type) forming a mature biofilm and L829 (tolC:cat) and L830 (acrB::aph) 181 
adhering as individual cells to the flow cell but unable to form a mature, three 182 
dimensional biofilm (figure 2). 183 
Mutants lacking a functional acrB or tolC do not have an altered aggregative 184 
ability 185 
To determine whether inactivation of AcrAB-TolC had altered the intrinsic 186 
aggregative nature of the strains lacking acrB or tolC a settle assay was used, this 187 
showed no significant difference in the aggregative ability of L829 (tolC::cat) or L830 188 
(acrB::aph) (Figure S1A). Salt aggregation tests also showed no defect in the 189 
mutants’ ability to aggregate. In fact, L829 (tolC::cat) cells aggregated in a lower 190 
concentration of ammonium sulphate than L828 (wild-type) showing a slightly greater 191 
tendency for cells to aggregate than the wild-type (Figure S1B). 192 
AcrAB-TolC does not export a factor required for biofilm formation 193 
If a soluble biofilm promoting factor was exported by AcrAB-TolC, addition of culture 194 
supernatant conditioned by growth with L828 (wild-type) should be able to rescue the 195 
ability of the tolC and acrB mutant strains to form a biofilm. However, two co-196 
  
incubation assays with wild-type and mutant strains suggested that there is no 197 
‘biofilm factor’ exported by AcrAB-TolC. Transwell assays showed the same poor 198 
ability to form a biofilm of the acrB and tolC mutants when incubated alone or co-199 
incubated with L828 (wild-type) (Figure S2). In addition, no rescue of the biofilm 200 
defect was observed when co-incubated with logarithmic or stationary phase cultures 201 
of L828 (wild-type) (Figure S2). Similarly, biofilm mat assays co-inoculated with an 202 
equal ratio of wild-type and mutants showed that mutant cells did not comprise any 203 
of the biofilm mats formed, whereas the corresponding planktonic culture comprised 204 
an equal mixture of mutant and wild-type cells (data not shown).  205 
Expression of efflux and biofilm regulator genes differs between acrB and tolC 206 
mutants and an acrA mutant 207 
To explore the key observation that L1271 (acrA::aph) was not compromised in its 208 
ability to form a biofilm we compared the expression of genes known to regulate 209 
efflux gene and curli gene expression between this strain and the acrB and tolC 210 
mutants.9,13 This analysis revealed that ramA is significantly over-expressed in acrB 211 
and tolC mutants but not in the acrA mutant.13 Expression of ramA in these strains 212 
was also measured by RT-PCR and a ramA promoter-gfp fusion and results were 213 
consistent in showing up-regulation of ramA in the acrB (average ~2 fold) and tolC 214 
(average ~4 fold) mutants but not in the acrA mutant. The transcriptome of a ramA 215 
over-expressing strain was also investigated to identify alterations in expression of 216 
biofilm relevant genes; L786 (SL1344 pTrc:::ramA) showed repression (two to five 217 
fold) of all the curli genes, including csgDEFG.7,11 This observation suggested that 218 
the biofilm defect in the acrB and tolC mutants was mediated by repression of curli 219 
biosynthesis and that this may be mediated by up-regulation of ramA.  220 
  
The lack of curli production in mutants lacking acrB and tolC is due to 221 
transcriptional repression 222 
Congo red supplemented agar and Congo red staining of bacterial suspensions 223 
showed qualitatively and quantitatively that curli expression is repressed in the tolC 224 
and acrB mutants and produced at wild-type levels in the acrA mutant.9 This lack of 225 
curli production was found to result from transcriptional repression of various genes 226 
in the curli biosynthetic loci, as measured by cRT-PCR including the regulator csgD 227 
and all the structural and assembly genes also needed to produce curli. Expression 228 
of these genes was repressed in the tolC and acrB mutants but not in the acrA 229 
mutant (Figure 3). 230 
Role of RamA, MarA and SoxS in repression of curli production and a loss of 231 
biofilm formation 232 
To investigate whether RamA, MarA and SoxS are able to repress biofilm formation 233 
each was over-expressed in L828 (wild-type) and the consequences investigated. 234 
Artificial over-expression of ramA in L828 (wild-type) resulted in a complete loss of 235 
the ability of the strain to form a biofilm, over-expression of marA and soxS also 236 
resulted in a loss of biofilm formation although to a lesser extent than that seen with 237 
ramA (Figure 4). Production of curli on Congo red agar was repressed in each over-238 
expression strain.  239 
Spatial expression of ramA, soxS and marA within colonies of L828 (wild-type), L829 240 
(tolC::cat) and L830 (acrB::aph) was visualised by fluorescence using regulator-gfp 241 
reporter plasmids. Figure 5 shows the pattern of expression seen for both ramA and 242 
marA was the inverse of where curli was being produced in each colony on Congo 243 
red agar. In wild-type colonies the highest ramA and marA expression was seen at 244 
the perimeter, where curli expression was at it’s lowest. In the tolC and acrB mutant, 245 
  
a higher level of ramA and marA expression is seen dispersed throughout the 246 
colony, again inversely correlating with phenotypic curli expression. 247 
Inactivation of the global regulators does not restore the ability of a tolC 248 
mutant to form a competent biofilm 249 
As all three regulators have the ability to repress biofilm formation when 250 
overexpressed and both marA and soxS are up-regulated upon inactivation of ramA, 251 
all three genes were inactivated to establish if rescue of biofilm formation would 252 
occur in tolC and acrB mutants. Inactivation of each of the regulators alone in the 253 
tolC and acrB mutants failed to rescue curli production and biofilm formation, 254 
however loss of each of the regulator genes was followed by consequent up-255 
regulation of the others which may compensate for their inactivation (Figure 6). A 256 
series of multiple mutants lacking combinations of the three regulators also failed to 257 
rescue biofilm formation (Figure 7 shows the lack of rescue of the tolC mutant by 258 
loss of marA, soxS and ramA). 259 
260 
  
Discussion 261 
Multidrug efflux pumps have a central role in the biology of bacteria with roles in drug 262 
resistance, cell division, pathogenicity and as recently described the formation of 263 
biofilms. 9,14 Here, we investigated the mechanism which explains the inability of 264 
mutants lacking AcrB and TolC, constituents of the major AcrAB-TolC system of 265 
Enterobacteriaceae, to form a competent biofilm. Mutants of Salmonella lacking a 266 
functional tolC or acrB were unable to form biofilms under various conditions and this 267 
was not related to any defect in growth, cellular hydrophobicity/aggregative ability or 268 
export of a biofilm promoting substrate. Surprisingly a mutant lacking a functional 269 
AcrA (but still expressing AcrB),10 was not defective in its ability to form a biofilm. 270 
Loss of acrA has previously been shown to result in hyper-susceptibility to various 271 
drugs and a decreased ability to attach to and invade epithelial cells in tissue 272 
culture.10 The phenotype of an acrA mutant was, however, distinct from that of 273 
mutants lacking acrB.10  One major difference between acrA and acrB/tolC mutants 274 
is expression of the global regulator ramA,13 known to positively regulate expression 275 
of acrAB and tolC as well as other genes. Expression of ramA was up-regulated in 276 
both acrB and tolC mutants but not in an acrA mutant and analysis of microarray 277 
data showed that ramA up-regulation was associated with decreased expression of 278 
curli biosynthetic genes,11 this led us to hypothesise that curli repression was the 279 
reason that the efflux mutants did not form a biofilm and that ramA has a role in the 280 
co-ordinated regulation of efflux and biofilm formation. We confirmed the absence of 281 
curli production in mutants lacking tolC or acrB is due to strict repression of all the 282 
curli biosynthetic genes. We also confirmed that ramA over-expression repressed 283 
curli production and completely abolished biofilm formation. However, inactivation of 284 
ramA in the tolC and acrB mutants did not rescue their ability to form a biofilm. To 285 
  
determine whether loss of ramA expression is compensated by other transcriptional 286 
activator genes, marA, soxS and rob expression was measured in mutant strains 287 
lacking ramRA, marRA or soxRS. 8,11,15-17 Loss of ramRA resulted in increased 288 
expression of marA and soxS, both of which have some known functional overlap 289 
with RamA.18-19 Furthermore, over-expression of each of ramA, marA and soxS 290 
resulted in repression of curli production and biofilm formation. This suggests 291 
repression of biofilm formation and curli expression may be a core role for 292 
transcriptional activators that respond to stress and co-ordinate efflux up-regulation. 293 
The regulation of curli expression is extremely complex with multiple pathways 294 
known to impact curli production. Amongst these pathways are two component 295 
systems which respond to membrane stress (cpxRA, rcsCB, envZ/ompR), rpoE and 296 
the lytic transglycosylases mltC and mltE. 20 All these systems have membrane or 297 
periplasmic bound components demonstrating that curli synthesis is sensitive to 298 
changes in the membrane. Whether RamA/MarA/SoxS) act directly to repress curli 299 
synthesis or via one of the other currently known pathways which can influence curli 300 
repression is not known. Although there is a suggested RamA/MarA/SoxS 301 
consensus binding site, there is no good match for this sequence within the curli 302 
locus suggesting that the action of these regulators in mediating curli repression is 303 
indirect. 7,21 Whilst we demonstrate here that over-expression of each of ramA, marA 304 
and soxS can repress biofilm we were unable to rescue the acrB and tolC mutants 305 
biofilm and curli production defect by inactivation of these genes individually or in 306 
combination. Therefore, while we have shown these regulators can repress biofilm 307 
formation in a manner phenotypically identical to that seen in response to loss of 308 
efflux it is unclear how important they are in mediating the biofilm defect seen in 309 
efflux mutants.  310 
  
The demonstration that biofilm formation and efflux are co-ordinately but inversely 311 
regulated with loss of function of multidrug efflux resulting in repression of biofilm is 312 
interesting. Both de-repression of AcrAB-TolC and formation of a biofilm are in 313 
themselves protective against antibiotic action, the inverse regulation observed here 314 
seems counterintuitive. This relationship may act as a paradigm for other systems in 315 
other species where a link between efflux and biofilm formation exists. It is possible 316 
that conditions where efflux is up-regulated in response to stress represent a 317 
hazardous environment where formation of a biofilm and the subsequent attachment 318 
to a single site is a poor survival strategy explaining the evolution of a genetic switch 319 
between the two.  320 
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Figure legends 406 
Figure 1. Crystal violet biofilm assay quantifies biofilm formation of L828 (wild-type), L829 407 
(tolC::cat), L830 (acrB::aph) and L1271 (acrA::aph), showing genetic inactivation of tolC or 408 
acrB creates an inability to form a biofilm. Asterisks indicate significantly different average 409 
values to wild-type (p<0.05). 410 
Figure 2. Phase contrast microscopy images of L828 (wild-type, panel A), L830 (acrB::aph, 411 
panel B) and L829 (tolC::cat, panel C) at 40 X magnification after 48 hours incubation under 412 
flow conditions.  413 
Figure 3. Expression of curli genes. A schematic of the curli biosynthesis genes with average 414 
expression values determined by RT-PCR used to colour each gene showing repression in 415 
the tolC and acrB mutants. All expression values less than 50% of the wild-type were 416 
statistically significantly different (p<0.05). 417 
Figure 4. Over-expression of ramA, marA or soxS represses biofilm formation.  The bar chart 418 
shows biofilm formation in the crystal violet assay by L828 carrying pTrc-marA or pTrc-soxS 419 
or pTrc-ramA without or with induction with 1mM IPTG. 420 
Figure 5. Expression of ramA and marA is up-regulated in efflux mutants and differentiated 421 
spatially within colonies shown by gfp reporter plasmids and correlates with a lack of curli 422 
production shown phenotypically on Congo red agar. 423 
Figure 6. Inactivation of the ram, mar or sox loci results in compensatory up-regulation of 424 
redundant regulators. The graph shows average expression data from RT-PCR in each 425 
mutant and shows that when ramRA is inactivated in L828 (wild-type) there is a large 426 
increase in expression of marA and soxS to compensate.  427 
Figure 7. Crystal violet biofilm assay shows loss of ramA, marA, soxS and combinations 428 
thereof does not rescue tolC mutant’s biofilm defect. Asterisks indicate significantly different 429 
average values to wild-type (p<0.05). 430 
 431 
 432 
  
Table 1. List of strains used in this study. 433 
Strain  Genotype Description Reference 
L828 14028S Wild-type Salmonella Typhimurium ATCC 
L829 14028S tolC::cat Mutant lacking TolC 6  
L830 14028S acrB::aph Mutant lacking AcrB 6  
L1271 14028S acrA::aph  Mutant lacking AcrA This study 
L1303 14028S ramRA::aph  Mutant lacking RamRA This study 
L1306 14028S tolC::cat, ramRA::aph  Mutant lacking TolC and RamRA This study 
L1506 14028S ΔtolC, ΔramA Mutant lacking TolC and RamA This study 
L1507 14028S ΔtolC, ΔramA, ΔsoxS Mutant lacking TolC, RamA and SoxS This study 
L1508 14028S ΔtolC,ΔramA, marA::aph Mutant lacking TolC, RamA and MarA This study 
L1509 14028S ΔtolC, ΔramA, ΔsoxS, marA::aph Mutant lacking TolC, RamA, SoxS and MarA This study 
L1511 14028S ramA::cat Mutant lacking RamA This study 
L1512 14028S acrB::aph, ramA::cat Mutant lacking AcrB and RamA This study 
N/A E. coli 042 Enteroaggregative E. coli ATCC  
    
Plasmid    
pTrc-marA marA over-expression plasmid This study 
pTrc-ramA ramA over-expression plasmid 7 
pTrc-soxS soxS over-expression plasmid This study 
pWKS30-marA-gfp marA gfp reporter plasmid This study 
pWKS30-ramA-gfp ramA gfp reporter plasmid This study 
pWKS30-soxS-gfp soxS gfp reporter plasmid This study 
434 
  
Table 2. Primers used in this study. 435 
Primer Sequence Description 
acrB-checkF GGATCACACCTTATTGCCAG acrB mutant check forward primer 
acrB-checkR TTAACAGTGATCGTCGGTCG acrB mutant check reverse primer 
tolC-checkF CTTCTATCATGCCGGCGACC tolC mutant check forward primer 
tolC-checkF CGCTTGCTGGCACTGACCTT tolC mutant check reverse primer 
acrA-checkF ACATCCAGGATGTGTTGTCG acrA mutant check forward primer 
acrA-checkF CAATCGTCGGATATTGCGCT acrA mutant check reverse primer 
pTrc-ramAF  ATGACCATTTCCGCTCAGGT pTrc-ramA cloning forward primer 
pTrc-ramAR  TCAATGCGTACGGCCATGCT pTrc-ramA cloning reverse primer 
pTrc-marAF  ATGTCCAGACGCAACACTGA pTrc-marA cloning forward primer 
pTrc-marAR  CTAGTAGTTGCCATGGTTCA pTrc-marA cloning reverse primer 
pTrc-soxSF  ATGTCGCATCAGCAGATAAT pTrc-soxS cloning forward primer 
pTrc-soxSR  CTACAGGCGGTGACGGTAAT pTrc-soxS cloning reverse primer 
marA-RTF CGCAACACTGACGCTATTAC marA qRT-PCR forward primer 
marA-RTR TTCAGCGGCAGCATATAC marA qRT-PCR reverse primer 
ramA-RTF TCCGCTCAGGTTATCGACAC ramA qRT-PCR forward primer 
ramA-RTR AGCTTCCGTTCACGCACGTA ramA qRT-PCR reverse primer 
soxS-RTF CATATCGACCAACCGCTA soxS qRT-PCR forward primer 
soxS-RTR CGGAATACACGCGAGAAG soxS qRT-PCR reverse primer 
16S-RTF CCTCAGCACATTGACGTTAC 16S qRT-PCR forward primer 
16S-RTR TTCCTCCAGATCTCTACGCA 16S qRT-PCR reverse primer 
  
csgA-RTF AGCATTCGCAGCAATCGTAG csgA qRT-PCR forward primer 
csgA-RTR TTAGCGTTCCACTGGTCGAT csgA qRT-PCR reverse primer 
csgB-RTF ATCAGGCGGCCATTATTGGT csgB qRT-PCR forward primer 
csgB-RTR TACTGGCATCGTTGGCATTG csgB qRT-PCR reverse primer 
csgC-RTF AATTCTCTCTGTGCGCGACG csgC qRT-PCR forward primer 
csgC-RTF GCAGTGATTGTCCGTCCGAA csgC qRT-PCR reverse primer 
csgD-RTF GGTATTCTGCGTGGCGAATG csgD qRT-PCR forward primer 
csgD-RTR AGTAATGCGGACTCGGTGCT csgD qRT-PCR reverse primer 
csgE-RTF ACGCTATCTGACCTGGATTG csgE qRT-PCR forward primer 
csgE-RTR CGTTATGGTGATCCAGCTTC csgE qRT-PCR reverse primer 
csgF-RTF GACGTTCCAGTTCGCTAATC csgF qRT-PCR forward primer 
csgF-RTR ATCGTTGGTCACCATACGTC csgF qRT-PCR reverse primer 
csgG-RTF CTGGAACGACAAGGCTTACA csgG qRT-PCR forward primer 
csgG-RTR TGATCCAGCTGATACTGCGT csgG qRT-PCR reverse primer 
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SUPPLEMETARY FIGURES 452 
Figure S1.  453 
Panel A. Settle assay of L828 (wild-type), L829 (tolC::cat) and L830 (acrB::aph). E. coli O42 454 
was used as a positive, aggregative control. Values indicate the percentage of an initial 455 
absorbance from readings taken immediately below the surface of the liquid of a broth which 456 
was incubated statically over a 24h period.  457 
Panel B. Salt aggregation test images of L828 (wild-type), L829 (tolC::cat) and L830 458 
(acrB::aph) in 1M and 2M ammonium sulphate. Aggregation was recorded as formation of a 459 
visible precipitate and the lowest concentration of ammonium sulphate to prompt 460 
precipitation recorded for each strain. 461 
 462 
Figure S2. Transwell assays show no rescue of biofilm formation by mutants when co-463 
incubated with wild-type. (A) shows strains incubated with and without the presence of L828 464 
inoculated at the same density as the mutants, (B) shows the same experiment but with co-465 
incubation with an overnight, undiluted culture of L828.  466 
467 
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